In addition, inhibition of S1PR1 can be achieved by targeting inhibited NSCLC cell proliferation, migration, and invasion, while inducing more NSCLC cell apoptosis [32,33]. The gene discussed is S1PR1; the disease is non-small cell lung carcinoma.